# Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases

> **NCT05774964** · PHASE2 · UNKNOWN · sponsor: **Liaoning Cancer Hospital & Institute** · enrollment: 100 (estimated)

## Conditions studied

- For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** S1
- **DRUG:** Cetuximab
- **DRUG:** Metronidazole
- **DRUG:** Vitamin A
- **DRUG:** Folic acid

## Key facts

- **NCT ID:** NCT05774964
- **Lead sponsor:** Liaoning Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-15
- **Primary completion:** 2025-03-15
- **Final completion:** 2025-03-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05774964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05774964, "Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05774964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*